Keen Vision Acquisition Corporation (KVAC)
NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 10.73 |
| Open | 10.72 |
| Bid | 10.70 x 200 |
| Ask | 10.77 x 200 |
| Day's range | 10.72 - 10.73 |
| 52-week range | 10.16 - 10.98 |
| Volume | |
| Avg. volume | 81,911 |
| Market cap | 207.798M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 21.04 |
| EPS (TTM) | 0.51 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireMedera Inc. to be Listed on NASDAQ Through a Merger Agreement with Keen Vision Acquisition Corporation
Keen Vision Acquisition Corporation ("KVAC") (Nasdaq: KVAC, KVACW) and Medera Inc., ("Medera"), a clinical-stage biotechnology company, announced today that they have entered into a definitive merger agreement. Upon closing of the merger, which is expected to occur in the fourth quarter of 2024, the combined company is to be named Medera Inc.
Simply Wall St.With 61% ownership, Keen Vision Acquisition Corporation (NASDAQ:KVAC) boasts of strong institutional backing
Key Insights Given the large stake in the stock by institutions, Keen Vision Acquisition's stock price might be...
- Simply Wall St.
Keen Vision Acquisition Corporation (NASDAQ:KVAC) most popular amongst retail investors who own 45% of the shares, institutions hold 32%
Key Insights Keen Vision Acquisition's significant retail investors ownership suggests that the key decisions are...
© 2024 Yahoo. All rights reserved.